CATALAYER NEWS

Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA - BioSpace

Source: BioSpace · 2026-01-05

Full article text is available in the Catalayer news terminal.

RELATED ON CATALAYER
Mentioned Tickers
$TGT · Target
Related Topics
Biotech & FDA NewsRetail & E-commerce NewsTech IPO & Private Market News
RELATED MARKETS
Prediction Markets
New Rihanna Album before GTA VI?52%New Playboi Carti Album before GTA VI?52%Will Jesus Christ return before GTA VI?48%
Open Catalayer terminal for live tracking →